P211: Enhancing Inspection Readiness: Best Practices for Pharmacovigilance Teams
Poster Presenter
Sue Lee
Director, Global Patient Safety Signal Management and Innovation
Takeda United States
Objectives
To provide an example for best practices for effective preparation, engagement, and post-inspection actions to enhance efficiency and compliance during pharmacovigilance regulatory inspections.
Method
Based on recent experience, a comprehensive synthesis of strategies for inspection readiness were developed, emphasizing proactive preparation, clear communication, cross-functional collaboration, and structured post-inspection responses.
Results
The proposed best practices effectively streamline inspection readiness, reduce compliance risks, and improve inspection outcomes. Case examples demonstrate how central coordination, cross-functional collaboration, and proactive audits ensure compliance with regulatory standards. Mock inspections and structured documentation systems enhance organizational readiness and confidence.
Conclusion
Proactive and continuous preparation, combined with systematic strategies, equips pharmacovigilance teams to navigate regulatory inspections effectively. These best practices foster a culture of compliance, ensure transparency, and uphold the commitment to patient safety and public trust in the pharmaceutical industry.
